Skip to main content
Premium Trial:

Request an Annual Quote

C-Path Using Rosetta's Resolver in Predictive Safety Testing Consortium

NEW YORK (GenomeWeb News) – The Critical Path Institute will use Rosetta Biosoftware’s Resolver system, Rosetta said today.
 
C-Path will use the software for data management and analysis in its Predictive Safety Testing Consortium, which is a collection of pharmaceutical companies that work with C-Path to share information that may help improve drug safety.
 
C-Path is a publicly funded research and education institute in Tuscon, Ariz., and is a research arm of the US Food and Drug Administration’s Critical Path Initiative.
 
Financial terms of the deal were not released.

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.